Herndon Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $20K | Hold |
269
| – | – | ﹤0.01% | 98 |
|
|
2017
Q1 | $18K | Sell |
269
-63
| -19% | -$4.22K | ﹤0.01% | 101 |
|
|
2016
Q4 | $21K | Buy |
332
+21
| +7% | +$1.33K | ﹤0.01% | 107 |
|
|
2016
Q3 | $20K | Sell |
311
-766
| -71% | -$49.3K | ﹤0.01% | 141 |
|
|
2016
Q2 | $80K | Sell |
1,077
-390
| -27% | -$29K | ﹤0.01% | 125 |
|
|
2016
Q1 | $98K | Buy |
1,467
+53
| +4% | +$3.54K | ﹤0.01% | 131 |
|
|
2015
Q4 | $96K | Buy |
1,414
+1,073
| +315% | +$72.8K | ﹤0.01% | 137 |
|
|
2015
Q3 | $18K | Buy |
341
+112
| +49% | +$5.91K | ﹤0.01% | 152 |
|
|
2015
Q2 | $14K | Buy |
+229
| New | +$14K | ﹤0.01% | 151 |
|